Intramuscular tranexamic acid results in lower peak plasma concentrations but comparable systemic absorption to intravenous administration in healthy dogs
American Journal of Veterinary Research · 01.11.2026 · 87 (11)
DOI: 10.2460/ajvr.26.06.0266 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, erschienen am 01.11.2026. Verfasst von Eun Ji Kwak und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO. Hauptthemen laut MEDLINE: Antifibrinolytic Agents, Tranexamic Acid. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To determine the pharmacokinetics of IM and IV tranexamic acid (TXA) in healthy dogs.
Methods
There were 6 healthy client-owned dogs that received TXA (20 mg/kg) in a randomized crossover study design with a 6-week washout period between IM and IV administration. Venous blood samples were collected from baseline to 8 hours after injection. Plasma TXA concentrations were measured using LC-MS-MS.
Results
For IM administration, mean ± SD maximum plasma concentration (C max ) was 46.8 ± 26.6 μg/mL, total area under the curve was 173.8 ± 25.0 μg/mL·h, time to C max was 1.6 ± 1.4 hours, half-life (t 1/2 ) was 2.8 ± 2.1 hours, and bioavailability was 120.9 ± 10.0%. For IV administration, C max was 119.8 ± 17.6 μg/mL, total area under the curve was 143.3 ± 10.5 μg/mL·h, and t 1/2 was 2.1 ± 1.8 hours.
Conclusions
IM C max reached approximately 39% of IV C max and exhibited a 33% longer t 1/2 , consistent with slower absorption. Despite the lower C max , bioavailability was 120.9%, suggesting that IM TXA maintained a higher plasma concentration for a longer duration. Clinical Relevance Although the prolonged time to C max associated with IM administration may limit its use in patients requiring rapid intervention, it offers practical advantages when IV access is delayed, allowing prehospital treatment prior to definitive veterinary care. Further investigation into IM dosing protocols is needed before it can be recommended in clinical patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.
- Emergency and Critical Care Services, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.
- Colorado State University, Fort Collins, CO.
- Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.
- Center for Companion Animal Studies, Translational Medicine Institute, Colorado State University, Fort Collins, CO.
- Pharmacology and Biomedical Engineering, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.
ORCID-Profile: Eun Ji Kwak, Kristin Zersen, Claire Tucker, Casey Lavender, Charles Talbot, Daniel Gustafson, Tara Hendry-Hofer, Kelly Hall
Zitieren
APA
Kwak, E. J., Zersen, K., Tucker, C., Lavender, C., Talbot, C., Gustafson, D., Hendry-Hofer, T., & Hall, K. (2026). Intramuscular tranexamic acid results in lower peak plasma concentrations but comparable systemic absorption to intravenous administration in healthy dogs. American Journal of Veterinary Research, 87(11). https://doi.org/10.2460/ajvr.26.06.0266
Vancouver
Kwak EJ, Zersen K, Tucker C, Lavender C, Talbot C, Gustafson D, et al. Intramuscular tranexamic acid results in lower peak plasma concentrations but comparable systemic absorption to intravenous administration in healthy dogs. American Journal of Veterinary Research. 2026;87(11). doi:10.2460/ajvr.26.06.0266
BibTeX
@article{Kwak2026,
author = {Kwak, Eun Ji and Zersen, Kristin and Tucker, Claire and Lavender, Casey and Talbot, Charles and Gustafson, Daniel and Hendry-Hofer, Tara and Hall, Kelly},
title = {Intramuscular tranexamic acid results in lower peak plasma concentrations but comparable systemic absorption to intravenous administration in healthy dogs},
journal = {American Journal of Veterinary Research},
year = {2026},
volume = {87},
number = {11},
doi = {10.2460/ajvr.26.06.0266}
}
EUVIMED